Skip to main content
SpringerLink
Log in

Health-related quality of life in high-grade glioma patients: a prospective single-center study

  • Original Article
  • Published:
Supportive Care in Cancer Aims and scope Submit manuscript

Abstract

Purpose

In this single center study, we aimed to assess quality of life and cognitive and emotional distress in patients treated for high-grade glioma.

Methods and materials

A hundred and eighteen patients with high-grade glioma were prospectively enrolled. We assessed HRQoL at baseline (after surgery before radiotherapy), at the end of radiotherapy and during follow-up (every 3 months for the first 2 years and every 6 months between 2 and 5 years) using the European Organization for Research and Treatment of Cancer Quality of Life Questionnaire 30 (EORTC-C30), Brain Cancer Module-20 (BN-20), Minimental State Examination (MMSE) and Hospital Anxiety and Depression Scale (HADS). Baseline scores, and first 18-month follow-up period scores were included to statistical analysis.

Results

Sixty-five (55%) patients had progressive tumor. Global score, physical, role and emotional function, insomnia (p for each <0.001) and appetite loss (p: 0.008) scores of EORTC-C30 significantly related to disease progression. According to BN-20 seizure and leg weakness (p < 0.001), drowsiness and bladder control (p: 0.002), motor dysfunction (p: 0.001), future uncertainty (p: 0.04), visual disorder (p: 0.008) and communication deficit (p: 0.006) symptoms significantly related to disease progression. There were significant decrements in orientation, attention and calculation and language scores (p values were 0.017, 0.005 and 0.003, respectively) of MMSE. The baseline and follow-up anxiety and depression scores did not differ significantly.

Conclusion

We conclude that there were many changes in patients with high-grade glioma during the course of the disease and most of them were related to disease progression.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

Similar content being viewed by others

References

  1. Osoba D, Brada M, Prados MD, Yung WKA (2000) Effect of disease burden on health-related quality of life in patients with malignant gliomas. Neuro-Oncol 2:221–228

    PubMed  CAS  Google Scholar 

  2. Eser S, Yakut C, Özdemir R, Karakılınç H, Özalan S, Marshall SF et al (2010) Cancer incidence rates in Turkey in 2006: a detailed registry based estimation. Asian Pacific J Cancer Prev 11:1731–1739

    Google Scholar 

  3. Hottinger AF, Yoon H, DeAngelis LM, Abrey LE (2009) Neurological outcome of long-term survivors. J Neurooncol 95:301–305

    Article  PubMed  Google Scholar 

  4. Stupp R, Mason WP, van den Bent MJ et al (2005) Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med 352:987–996

    Article  PubMed  CAS  Google Scholar 

  5. Heimans JJ, Taphorn MJB (2002) Impact of brain tumor treatment on quality of life. J Neurol 249:955–960

    Article  PubMed  Google Scholar 

  6. Stucki G, Kroeling P (2003) Principles of rehabilitation. In: Hochberg MC, Silman AJ, Smolen JS, Weinblatt ME, Weisman MH (eds) Rheumatology. Mosby, Toronto, pp 517–530

    Google Scholar 

  7. The WHOQOL Group (1994) The development of the World Health Organization Quality of Life assessment (the WOQOL). In: Orley J, Kuyken W (eds) Quality of life assessment: international prospective. Springer, Heidelberg, pp 41–57

    Chapter  Google Scholar 

  8. Taphoorn MJB, van den Bent MJ, Maurer MEL et al (2007) Health-related quality of life in patients treated for anaplastic oligodendroglioma with adjuvant chemotherapy: results of a European organization for research and treatment of cancer randomized clinical trial. J Clin Oncol 25:5723–5730

    Article  PubMed  Google Scholar 

  9. Aaronson NK, Bullinger M, Ahmedzai S (1988) A modular approach to quality-of-life assessment in cancer clinical trials. Recent Results Cancer Res 111:231–249

    Article  PubMed  CAS  Google Scholar 

  10. Bellamy N (2003) Principles of outcome assessment. In: Hochberg MC, Silman AJ, Smolen JS, Weinblatt ME, Weisman MH (eds) Rheumatology. Mosby, Toronto, pp 21–30

    Google Scholar 

  11. Montazeri A, Milroy R, Hole D et al (2001) Quality of life in lung cancer patients: as an important prognostic factor. Lung Cancer 31:233–240

    Article  PubMed  CAS  Google Scholar 

  12. Kaasa S, Mastekaasa A, Lund E (1989) Prognostic factors for patients with inoperable non-small cell lung cancer, limited disease. The importance of patients’ subjective experience of disease and psychosocial well-being. Radiother Oncol 15:235–242

    Article  PubMed  CAS  Google Scholar 

  13. Garratt A, Schmidt L, Mackintosh A, Fitzpatric R (2002) Quality of life measurement: bibliographic study of patient assessed health outcome measures. British Med J 15:141–147

    Google Scholar 

  14. Aaronson NK, Ahmedzai S, Bergman B, Bullinger M, Cull A, Duez NJ (1993) The European Organization for Research and Treatment of Cancer EORTC C30: a quality of life instrument for use in international clinical trials in oncology. J Natl Cancer Inst 85:365–376

    Article  PubMed  CAS  Google Scholar 

  15. Fayers PM, Aaronson NK, Bjordal K, Groenvold M, Curan D, Bottomley A, on behalf of the EORTC Quality of Life Study Group (2001) The EORTC QLQ-C30 scoring manual, 3rd edn. European Organization for Research and Treatment of Cancer, Brussels

    Google Scholar 

  16. Folstein MF, Folstein S (1975) McHugh PR: “Mini-mental state”: a practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 12:189–198

    Article  PubMed  CAS  Google Scholar 

  17. Zigmond AS, Snaith RP (1983) The hospital anxiety and depression scale. Acta Psychiatr Scand 67:361–370

    Article  PubMed  CAS  Google Scholar 

  18. Hottinger AF, Youn H, De Angelis LM, Abrey LE (2009) Neurological outcome of long-term glioblastoma survivals J. Neurooncol 95:301–305

    Article  Google Scholar 

  19. Efficace F, Bottomley A (2002) Health related quality of life assessment methodology and reported outcomes in randomized controlled trials of primary brain cancer patients. Eur J Cancer 38:1824–1831

    Article  PubMed  CAS  Google Scholar 

  20. Hart MG, Grant R, Garside R, et al. (2008) Temozolomide for high grade glioma. Cochrane Database Syst Rev (4):CD007415

  21. Lipscomb J, Gotay CC, Snyder CF (2007) Patient-reported outcomes in cancer: a review of recent research and policy initiatives. CA Cancer J Clin 57:278–300

    Article  PubMed  Google Scholar 

  22. Budrukkar A, Jalali R, Dutta D et al (2009) Prospective assessment of quality of life in adult patients with primary brain tumors in routine neurooncology practice. J Neurooncol 95:413–419

    Article  PubMed  Google Scholar 

  23. Taphoorn M, Stupp R, Coens C, Osoba D et al (2005) Health-related quality of life in patients with glioblastoma: a randomized controlled trial. Lancet Oncol 6:937–944

    Article  PubMed  Google Scholar 

  24. Addeo R, Caraglia M, Faiola V et al (2007) Concomitant treatment of brain metastasis with whole brain radiotherapy and temozolomide is active and improves quality of life. BMC Cancer 7:18

    Article  PubMed  Google Scholar 

  25. Jalali R, Datta D (2008) Prospective analysis of incidence of central nervous system tumors presenting in a tertiary cancer hospital from India. J Neurooncol 87:111–114

    Article  PubMed  Google Scholar 

  26. Guillemin F, Bombardier C, Beaton D (1993) Cross-cultural adaptation of health-related quality of life measures: literature review and proposed guidelines. J Clin Epidemiol 46:1417–1432

    Article  PubMed  CAS  Google Scholar 

  27. Kleinman A, Eisenberg L, Good B (1978) Culture, illness and care: clinical lessons from anthropologic and cross-cultural research. Ann Intern Med 88:251–258

    PubMed  CAS  Google Scholar 

  28. Mainio A, Hakko H, Niemela A, Koivukangas J, Rasanen P (2006) Gender difference in relation to depression and quality of life among patients with a primary brain tumor. Eur Psychiatry 21:194–199

    Article  PubMed  Google Scholar 

  29. Rogers MP, Orav J, Black PM (2001) The use of a simple Likert scale to measure quality of life in brain tumor patients. J Neurooncol 55:121–131

    Article  PubMed  CAS  Google Scholar 

  30. Janda M, Steginga S, Langbecker D, Dunn J, Walker D, Eakin E (2007) Quality of life among patients with a brain tumor and their carers. J Psychosom Res 63:617–623

    Article  PubMed  Google Scholar 

  31. Cheng J, Zhang X, Liu B (2009) Health-related quality of life in patients with high-grade glioma. Neuro-Oncology 11:41–50

    Article  PubMed  Google Scholar 

  32. Hahn CA, Dunn RH, Logue PE, King JH, Edwards CL, Halperin EC (2003) Prospective study of neuropsychologic testing and quality-of-life assessment of adults with primary malignant brain tumors. Int J Radiat Oncol Biol Phys 55:992–999

    Article  PubMed  CAS  Google Scholar 

  33. Hom J, Reitan RM (1984) Neuropsychological correlates of rapidly vs. slowly growing intrinsic cerebral neoplasms. J Clin Neuropsychol 6:309–324

    Article  PubMed  CAS  Google Scholar 

  34. Klein M, Taphoorn MJ, Heimans JJ et al (2001) Neurobehavioral status and health-related quality of life in newly diagnosed high-grade glioma patients. J Clin Oncol 19:4037–4047

    PubMed  CAS  Google Scholar 

  35. Salo J, Niemela A, Joukamaa M, Koivukangas J (2002) Effect of brain tumor laterality on patients’ perceived quality of life. J Neurol Neurosurg Psychiatry 72:373–377

    Article  PubMed  CAS  Google Scholar 

  36. Brown PD, Buckner JC, O’Fallon JR et al (2003) Effects of radiotherapy on cognitive function in patients with low-grade glioma measured by the Folstein Mini-Mental State Examination. J Clin Oncol 21:2519–2524

    Article  PubMed  Google Scholar 

  37. Mauer M, Stupp R, Taphoorn MJ et al (2007) The prognostic value of health-related quality-of-life data in predicting survival in glioblastoma cancer patients: results from an international randomized phase III EORTC Brain Tumor and Radiation Oncology Groups, and NCIC Clinical Trials Group study. Br J Cancer 97:302–307

    Article  PubMed  CAS  Google Scholar 

  38. Bosma I, Reijneveld JC, Douw L, Vos MJ, Postma TJ et al (2008) Health-related quality of life of long-term high-grade glioma survivors. Neuro-Oncol 11:51–58

    Article  PubMed  Google Scholar 

  39. Meyers CA, Hess KR, Yung WK, Levin VA (2000) Cognitive function as a predictor of survival in patients with recurrent malignant glioma. J Clin Oncol 18:646–650

    PubMed  CAS  Google Scholar 

  40. Klein M, Postma TJ, Taphoorn MJ et al (2003) The prognostic value of cognitive functioning in the survival of patients with high-grade glioma. Neurology 61:1796–1798

    Article  PubMed  CAS  Google Scholar 

  41. Pelletier G, Verhoef MJ, Khatri N, Hagen N (2002) Quality of life in brain tumor patients: the relative contributions of depression, fatigue, emotional distress, and existential issues. J Neurooncol 57:41–49

    Article  PubMed  Google Scholar 

  42. Litofsky NS, Farace E, Anderson F et al (2004) Depression in patients with high-grade glioma: results of the Glioma Outcomes Project. Neurosurgery 54:358–366

    Article  PubMed  Google Scholar 

  43. Osoba D, Brada M, Yung WKA, Prados M (2000) Health related quality of life in patients treated with temozolomide versus procarbazine for recurrent glioblastoma multiforme. J Clin Oncol 18:1481–1491

    PubMed  CAS  Google Scholar 

  44. Kirschbaum C, Wolf OT, May M, Wippich W, Hellhammer DH (1996) Stress and treatment induced elevations of corticosteroid levels associated with in impaired declarative memory in healthy adults. Life Sci 58:1475–1483

    Article  PubMed  CAS  Google Scholar 

  45. Newcomer JW, Craft S, Hershey T, Askins K, Bardgett ME (1994) Glucocorticoid-induced impairment in declarative memory performance in adult humans. J Neurosci 14:2047–2053

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Faculty of Medicine, Department of Radiation Oncology, Hacettepe University, Ankara, 06100, Turkey

    Cagdas Yavas, Faruk Zorlu, Gokhan Ozyigit, Murat Gurkaynak, Guler Yavas, Mustafa Cengiz, Ferah Yildiz & Fadil Akyol

  2. Faculty of Medicine, Department of Preventive Oncology, Hacettepe University, Ankara, 06100, Turkey

    Deniz Yuce

Authors
  1. Cagdas Yavas
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Faruk Zorlu
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Gokhan Ozyigit
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Murat Gurkaynak
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Guler Yavas
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Deniz Yuce
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Mustafa Cengiz
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Ferah Yildiz
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Fadil Akyol
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Cagdas Yavas.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Yavas, C., Zorlu, F., Ozyigit, G. et al. Health-related quality of life in high-grade glioma patients: a prospective single-center study. Support Care Cancer 20, 2315–2325 (2012). https://doi.org/10.1007/s00520-011-1340-4

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00520-011-1340-4

Keywords

Search

Navigation